Teva's Weltruza Seen as Launch-Execution Story After Clean Label, Oppenheimer Says

MT newswire2026/10/09 16:52

12:52 PM EDT, 10/09/2026 (MT Newswires) -- Teva Pharmaceutical Industries' (TEVA) Weltruza approval removes the label risk that defined the long-acting olanzapine debate, leaving launch execution as the key question, Oppenheimer said in a note Friday. With no REMS, no post-injection observation requirement and no boxed warning for post-injection delirium sedation syndrome, Weltruza is the first practical olanzapine LAI, the firm said. Oppenheimer expects a quiet first half of 2027 focused on sampling, hospital formularies and state-by-state Medicaid additions, with meaningful revenue in the second half. It said the launch should be judged on samples, formulary wins and prescriptions, not early sales. The $3,950 monthly list price, 47% above Oppenheimer's initial assumption, signals Teva's confidence in the profile, the firm said. It assumes a 40% gross-to-net discount and flagged rebate depth as the key variable through 2027. Oppenheimer raised its price target to $52 from $50 and reiterated its outperform rating. Price: 41.64, Change: +2.39, Percent Change: +6.08

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Oil price shocks combined with the AI boom create a stark contrast for emerging Asian currencies

The surge in oil prices and the artificial intelligence (AI) boom are intensifying the divergence in the foreign exchange market.

智通财经•2026/10/27 07:01

Google (GOOGL.US) earnings night may avoid 'moment of reckoning': financing and capital expenditure guidance take the lead, founders moving out of California eases concerns over stock sales

Wall Street analysts say that as the latest earnings season approaches, Google investors hold several advantageous positions, whereas Meta investors were not as fortunate previously—Meta's last earnings release revealed multiple disappointing factors that surprised the market.

智通财经•2026/10/27 07:01

DL Holdings Plans Investor Meetings to Review Third-Quarter Results

Bitget•2026/10/27 06:54

Japan’s Katayama says government is prepared to take decisive steps in FX market

FXStreet•2026/10/27 06:42